To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes
Critical appraisal of the ACCORD, ADVANCE and UKPDS follow-up randomised controlled trials concerning the cardiovascular effects of lowering glucose levels to near-normal on patients with type 2 diabetes. Interventions, outcomes, the interpretation of results and the guidelines in use are discussed....
Gespeichert in:
| Veröffentlicht in: | Evidence-based nursing 2009-01, Vol.12 (1), p.4-6 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6 |
|---|---|
| container_issue | 1 |
| container_start_page | 4 |
| container_title | Evidence-based nursing |
| container_volume | 12 |
| creator | Sherifali, Diana Punthakee, Zubin |
| description | Critical appraisal of the ACCORD, ADVANCE and UKPDS follow-up randomised controlled trials concerning the cardiovascular effects of lowering glucose levels to near-normal on patients with type 2 diabetes. Interventions, outcomes, the interpretation of results and the guidelines in use are discussed. [(BNI unique abstract)] 13 references |
| doi_str_mv | 10.1136/ebn.12.1.4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_764379101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66754910</sourcerecordid><originalsourceid>FETCH-LOGICAL-b328t-e379ef915d5f2200de30c2582500a7ef452f3da3d0a788fe1ee946843b0e01f53</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhoMotl298QdIQKwgzJrvmbkSWfzCVRHr4l3IZE7a2c4kNcnU9t-bZRcFL3qVnJOH8568L0JPKFlSytUr6PySsiVdinvomArVVK2izf1y56qulOTtETpJaUtIacjmITqiLSW8YfIY3ZwFPIbfEHGI2IeM86F-jT-by8Gf4wQ-AQ4O5wvAo8mQMo6QwER7gYPHg8-FGK4Bn4-31sA0WGyDzzGM2PgeWxP7IVybZOfRFJk52zBBeoQeODMmeHw4F-jHu7dnqw_V-uv7j6s366rjrMkV8LoF11LZS8cYIT1wYpksuxNianBCMsd7w_tSNY0DCtAWBwTvCBDqJF-gF_u5VzH8msvyehqShXE0HsKcdK1EkaDFmgU6vZNUqpZiZ9wCPfsP3IY5-vILTetGECKZ3Am_3FM2hpQiOH0Vh8nEW02J3uWmS26aMk21KPDTw8i5m6D_hx6CKkC1B4aU4ebvu4mXWtW8lvrLZqWbT9--i5-btd4U_vme76btXcJ_ANeirwM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784005255</pqid></control><display><type>article</type><title>To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Sherifali, Diana ; Punthakee, Zubin</creator><creatorcontrib>Sherifali, Diana ; Punthakee, Zubin</creatorcontrib><description>Critical appraisal of the ACCORD, ADVANCE and UKPDS follow-up randomised controlled trials concerning the cardiovascular effects of lowering glucose levels to near-normal on patients with type 2 diabetes. Interventions, outcomes, the interpretation of results and the guidelines in use are discussed. [(BNI unique abstract)] 13 references</description><identifier>ISSN: 1367-6539</identifier><identifier>EISSN: 1468-9618</identifier><identifier>DOI: 10.1136/ebn.12.1.4</identifier><identifier>PMID: 19103825</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd and RCN Publishing Company Ltd</publisher><subject>Blood Glucose - drug effects ; Cardiovascular Diseases - prevention & control ; Clinical medicine ; Clinical practice guidelines ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetic Angiopathies - prevention & control ; Glucose ; Heart attacks ; Hemoglobin ; Humans ; Hyperglycemia - drug therapy ; Insulin ; Intervention ; Nursing ; Treatment Outcome</subject><ispartof>Evidence-based nursing, 2009-01, Vol.12 (1), p.4-6</ispartof><rights>2009 RCN Publishing Company Limited and BMJ Publishing Group Ltd</rights><rights>Copyright: 2009 2009 RCN Publishing Company Limited and BMJ Publishing Group Ltd</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b328t-e379ef915d5f2200de30c2582500a7ef452f3da3d0a788fe1ee946843b0e01f53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ebn.bmj.com/content/12/1/4.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ebn.bmj.com/content/12/1/4.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19103825$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sherifali, Diana</creatorcontrib><creatorcontrib>Punthakee, Zubin</creatorcontrib><title>To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes</title><title>Evidence-based nursing</title><addtitle>Evid Based Nurs</addtitle><description>Critical appraisal of the ACCORD, ADVANCE and UKPDS follow-up randomised controlled trials concerning the cardiovascular effects of lowering glucose levels to near-normal on patients with type 2 diabetes. Interventions, outcomes, the interpretation of results and the guidelines in use are discussed. [(BNI unique abstract)] 13 references</description><subject>Blood Glucose - drug effects</subject><subject>Cardiovascular Diseases - prevention & control</subject><subject>Clinical medicine</subject><subject>Clinical practice guidelines</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetic Angiopathies - prevention & control</subject><subject>Glucose</subject><subject>Heart attacks</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hyperglycemia - drug therapy</subject><subject>Insulin</subject><subject>Intervention</subject><subject>Nursing</subject><subject>Treatment Outcome</subject><issn>1367-6539</issn><issn>1468-9618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kV1rFDEUhoMotl298QdIQKwgzJrvmbkSWfzCVRHr4l3IZE7a2c4kNcnU9t-bZRcFL3qVnJOH8568L0JPKFlSytUr6PySsiVdinvomArVVK2izf1y56qulOTtETpJaUtIacjmITqiLSW8YfIY3ZwFPIbfEHGI2IeM86F-jT-by8Gf4wQ-AQ4O5wvAo8mQMo6QwER7gYPHg8-FGK4Bn4-31sA0WGyDzzGM2PgeWxP7IVybZOfRFJk52zBBeoQeODMmeHw4F-jHu7dnqw_V-uv7j6s366rjrMkV8LoF11LZS8cYIT1wYpksuxNianBCMsd7w_tSNY0DCtAWBwTvCBDqJF-gF_u5VzH8msvyehqShXE0HsKcdK1EkaDFmgU6vZNUqpZiZ9wCPfsP3IY5-vILTetGECKZ3Am_3FM2hpQiOH0Vh8nEW02J3uWmS26aMk21KPDTw8i5m6D_hx6CKkC1B4aU4ebvu4mXWtW8lvrLZqWbT9--i5-btd4U_vme76btXcJ_ANeirwM</recordid><startdate>200901</startdate><enddate>200901</enddate><creator>Sherifali, Diana</creator><creator>Punthakee, Zubin</creator><general>BMJ Publishing Group Ltd and RCN Publishing Company Ltd</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope></search><sort><creationdate>200901</creationdate><title>To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes</title><author>Sherifali, Diana ; Punthakee, Zubin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b328t-e379ef915d5f2200de30c2582500a7ef452f3da3d0a788fe1ee946843b0e01f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Blood Glucose - drug effects</topic><topic>Cardiovascular Diseases - prevention & control</topic><topic>Clinical medicine</topic><topic>Clinical practice guidelines</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetic Angiopathies - prevention & control</topic><topic>Glucose</topic><topic>Heart attacks</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hyperglycemia - drug therapy</topic><topic>Insulin</topic><topic>Intervention</topic><topic>Nursing</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Sherifali, Diana</creatorcontrib><creatorcontrib>Punthakee, Zubin</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><jtitle>Evidence-based nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sherifali, Diana</au><au>Punthakee, Zubin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes</atitle><jtitle>Evidence-based nursing</jtitle><addtitle>Evid Based Nurs</addtitle><date>2009-01</date><risdate>2009</risdate><volume>12</volume><issue>1</issue><spage>4</spage><epage>6</epage><pages>4-6</pages><issn>1367-6539</issn><eissn>1468-9618</eissn><abstract>Critical appraisal of the ACCORD, ADVANCE and UKPDS follow-up randomised controlled trials concerning the cardiovascular effects of lowering glucose levels to near-normal on patients with type 2 diabetes. Interventions, outcomes, the interpretation of results and the guidelines in use are discussed. [(BNI unique abstract)] 13 references</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd and RCN Publishing Company Ltd</pub><pmid>19103825</pmid><doi>10.1136/ebn.12.1.4</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1367-6539 |
| ispartof | Evidence-based nursing, 2009-01, Vol.12 (1), p.4-6 |
| issn | 1367-6539 1468-9618 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_764379101 |
| source | MEDLINE; BMJ Journals - NESLi2 |
| subjects | Blood Glucose - drug effects Cardiovascular Diseases - prevention & control Clinical medicine Clinical practice guidelines Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetic Angiopathies - prevention & control Glucose Heart attacks Hemoglobin Humans Hyperglycemia - drug therapy Insulin Intervention Nursing Treatment Outcome |
| title | To lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A12%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=To%20lower%20or%20not%20to%20lower?%20Making%20sense%20of%20the%20latest%20research%20on%20intensive%20glycaemic%20control%20and%20cardiovascular%20outcomes&rft.jtitle=Evidence-based%20nursing&rft.au=Sherifali,%20Diana&rft.date=2009-01&rft.volume=12&rft.issue=1&rft.spage=4&rft.epage=6&rft.pages=4-6&rft.issn=1367-6539&rft.eissn=1468-9618&rft_id=info:doi/10.1136/ebn.12.1.4&rft_dat=%3Cproquest_cross%3E66754910%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1784005255&rft_id=info:pmid/19103825&rfr_iscdi=true |